Intraseptal galanin potentiates scopolamine impairment of delayed nonmatching to sample

John K. Robinson, Jacqueline Crawley

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Galanin coexists with ACh in the basal forebrain and medial septa) region. The present study investigated the interactions of the muscarinic receptor antagonist scopolamine and the neuropeptide galanin on an operant spatial delayed nonmatching to sample task (DNMTS) in rats. Scopolamine administered both intraperitoneally and microinjected into the medial septum impaired performance on DNMTS. Galanin administered alone into the medial septum did not disrupt DNMTS, but potentiated the disruptive effects of intraperitoneal administered scopolamine. These findings raise the possibility that endogenous galanin may exacerbate cognitive impairments associated with forebrain cholinergic deficits.

Original languageEnglish (US)
Pages (from-to)5119-5125
Number of pages7
JournalJournal of Neuroscience
Volume13
Issue number12
StatePublished - 1993
Externally publishedYes

Fingerprint

Galanin
Scopolamine Hydrobromide
Muscarinic Antagonists
Muscarinic Receptors
Prosencephalon
Neuropeptides
Cholinergic Agents

Keywords

  • ACh
  • Coexistence
  • Learning
  • Medial septum
  • Memory
  • Microinjection
  • Neuropeptide
  • Retention
  • Septohippocampal pathway

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Intraseptal galanin potentiates scopolamine impairment of delayed nonmatching to sample. / Robinson, John K.; Crawley, Jacqueline.

In: Journal of Neuroscience, Vol. 13, No. 12, 1993, p. 5119-5125.

Research output: Contribution to journalArticle

@article{a8fa2d0be6eb48a9a23dce84be5e52a1,
title = "Intraseptal galanin potentiates scopolamine impairment of delayed nonmatching to sample",
abstract = "Galanin coexists with ACh in the basal forebrain and medial septa) region. The present study investigated the interactions of the muscarinic receptor antagonist scopolamine and the neuropeptide galanin on an operant spatial delayed nonmatching to sample task (DNMTS) in rats. Scopolamine administered both intraperitoneally and microinjected into the medial septum impaired performance on DNMTS. Galanin administered alone into the medial septum did not disrupt DNMTS, but potentiated the disruptive effects of intraperitoneal administered scopolamine. These findings raise the possibility that endogenous galanin may exacerbate cognitive impairments associated with forebrain cholinergic deficits.",
keywords = "ACh, Coexistence, Learning, Medial septum, Memory, Microinjection, Neuropeptide, Retention, Septohippocampal pathway",
author = "Robinson, {John K.} and Jacqueline Crawley",
year = "1993",
language = "English (US)",
volume = "13",
pages = "5119--5125",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "12",

}

TY - JOUR

T1 - Intraseptal galanin potentiates scopolamine impairment of delayed nonmatching to sample

AU - Robinson, John K.

AU - Crawley, Jacqueline

PY - 1993

Y1 - 1993

N2 - Galanin coexists with ACh in the basal forebrain and medial septa) region. The present study investigated the interactions of the muscarinic receptor antagonist scopolamine and the neuropeptide galanin on an operant spatial delayed nonmatching to sample task (DNMTS) in rats. Scopolamine administered both intraperitoneally and microinjected into the medial septum impaired performance on DNMTS. Galanin administered alone into the medial septum did not disrupt DNMTS, but potentiated the disruptive effects of intraperitoneal administered scopolamine. These findings raise the possibility that endogenous galanin may exacerbate cognitive impairments associated with forebrain cholinergic deficits.

AB - Galanin coexists with ACh in the basal forebrain and medial septa) region. The present study investigated the interactions of the muscarinic receptor antagonist scopolamine and the neuropeptide galanin on an operant spatial delayed nonmatching to sample task (DNMTS) in rats. Scopolamine administered both intraperitoneally and microinjected into the medial septum impaired performance on DNMTS. Galanin administered alone into the medial septum did not disrupt DNMTS, but potentiated the disruptive effects of intraperitoneal administered scopolamine. These findings raise the possibility that endogenous galanin may exacerbate cognitive impairments associated with forebrain cholinergic deficits.

KW - ACh

KW - Coexistence

KW - Learning

KW - Medial septum

KW - Memory

KW - Microinjection

KW - Neuropeptide

KW - Retention

KW - Septohippocampal pathway

UR - http://www.scopus.com/inward/record.url?scp=0027135967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027135967&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 5119

EP - 5125

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 12

ER -